Cargando…

Management of Biochemical Recurrence after Primary Localized Therapy for Prostate Cancer

Clinically localized prostate cancer is typically managed by well established therapies like radical prostatectomy, brachytherapy, and external beam radiation therapy. While many patients can be cured with definitive local therapy, some will have biochemical recurrence (BCR) of disease detected by a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Darwish, Oussama M., Raj, Ganesh V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2012
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358653/ https://www.ncbi.nlm.nih.gov/pubmed/22655274 http://dx.doi.org/10.3389/fonc.2012.00048

Ejemplares similares

General Commentary to the “Management of Biochemical Recurrence after Primary Localized Therapy for Prostate Cancer” by Darwish O. M. and Raj G. V.
por: Shilkrut, Mark, et al.
Publicado: (2012)

Radiomics of Multiparametric MRI to Predict Biochemical Recurrence of Localized Prostate Cancer After Radiation Therapy
por: Zhong, Qiu-Zi, et al.
Publicado: (2020)

The Values of Systemic Immune-Inflammation Index and Neutrophil–Lymphocyte Ratio in Predicting Biochemical Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy
por: Wang, Shuo, et al.
Publicado: (2022)

Targeting Local Recurrence After Surgery With MRI Imaging for Prostate Cancer in the Setting of Salvage Radiation Therapy
por: Renard-Penna, Raphaële, et al.
Publicado: (2022)

Advanced Imaging of Biochemical Recurrent Prostate Cancer With PET, MRI, and Radiomics
por: Shaikh, Faiq, et al.
Publicado: (2020)

Cryosurgery Versus Primary Androgen Deprivation Therapy for Locally Recurrent Prostate Cancer After Primary Radiotherapy: A Propensity-Matched Survival Analysis
por: Bauman, Glenn, et al.
Publicado: (2020)

Identification of tumor-agnostic biomarkers for predicting prostate cancer progression and biochemical recurrence
por: Lautert-Dutra, William, et al.
Publicado: (2023)

The impact of adjuvant therapy in patients with biochemical recurrence on prostate cancer progression and mortality five years after radical prostatectomy
por: Fryczkowski, Mieczysław, et al.
Publicado: (2011)

Characterization of 7-Methylguanosine Identified Biochemical Recurrence and Tumor Immune Microenvironment in Prostate Cancer
por: Xin, Sheng, et al.
Publicado: (2022)

Identification and validation of a lipid metabolism gene signature for predicting biochemical recurrence of prostate cancer after radical prostatectomy
por: Cai, Yingxin, et al.
Publicado: (2022)

EMT Markers in Locally-Advanced Prostate Cancer: Predicting Recurrence?
por: Cheaito, Katia A., et al.
Publicado: (2019)

Pancreatic metastasis from locally recurrent neuroendocrine differentiated prostate cancer after radical prostatectomy
por: Ando, Takashi, et al.
Publicado: (2020)

Diagnostic performance of 99mTc-HYNIC-PSMA SPECT/CT for biochemically recurrent prostate cancer after radical prostatectomy
por: Li, Bo, et al.
Publicado: (2022)

The effects of PSA kinetics on the outcome of hypofractionated salvage radiotherapy for biochemical recurrence of prostate cancer after prostatectomy
por: Ishikawa, Hitoshi, et al.
Publicado: (2020)

Management of Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Patients After Primary Fertility-Sparing Therapy
por: Chen, Junyu, et al.
Publicado: (2021)

Dose-Intensified Stereotactic Ablative Radiation for Localized Prostate Cancer
por: Chen, Lily, et al.
Publicado: (2022)

Statin Use and the Risk of Prostate Cancer Biochemical Recurrence Following Definitive Therapy: A Systematic Review and Meta-Analysis of Cohort Studies
por: Sun, Jian-Xuan, et al.
Publicado: (2022)

Preoperative Predictors of Biochemical Recurrence-Free Survival in High-Risk Prostate Cancer Following Radical Prostatectomy
por: Nkengurutse, Gerard, et al.
Publicado: (2020)

Identification of a prognostic biomarker predicting biochemical recurrence and construction of a novel nomogram for prostate cancer
por: Yu, Zhaojun, et al.
Publicado: (2023)

Stereotactic Re-irradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: Preliminary Results
por: Olivier, Jonathan, et al.
Publicado: (2019)

Risk Factors for Biochemical Recurrence After PSMA-PET-Guided Definitive Radiotherapy in Patients With De Novo Lymph Node-Positive Prostate Cancer
por: Spohn, Simon K.B., et al.
Publicado: (2022)

Proton therapy for isolated local regional recurrence of breast cancer after mastectomy alone
por: Laughlin, Brady S., et al.
Publicado: (2022)

Salvage Reirradiation Options for Locally Recurrent Prostate Cancer: A Systematic Review
por: Zhong, Jim, et al.
Publicado: (2021)

Prediction of Biochemical Recurrence-Free Survival of Prostate Cancer Patients Leveraging Multiple Gene Expression Profiles in Tumor Microenvironment
por: Zhou, Rui, et al.
Publicado: (2021)

A Gene Prognostic Index Associated With Epithelial-Mesenchymal Transition Predicting Biochemical Recurrence and Tumor Chemoresistance for Prostate Cancer
por: Feng, Dechao, et al.
Publicado: (2022)

Stereotactic Body Radiation Therapy for Locally Progressive and Recurrent Pancreatic Cancer after Prior Radiation
por: Sutera, Philip, et al.
Publicado: (2018)

Detection rate of fluorine-18 prostate-specific membrane antigen-1007 PET/CT for prostate cancer in primary staging and biochemical recurrence with different serum PSA levels: A systematic review and meta-analysis
por: Liu, Xue, et al.
Publicado: (2022)

Low Incidence of Fatigue after Hypofractionated Stereotactic Body Radiation Therapy for Localized Prostate Cancer
por: Dash, Chiranjeev, et al.
Publicado: (2012)

WWOX Polymorphisms as Predictors of the Biochemical Recurrence of Localized Prostate Cancer after Radical Prostatectomy
por: Lin, Chia-Yen, et al.
Publicado: (2023)

Role of lymphatic invasion in predicting biochemical recurrence after radical prostatectomy
por: Chung, Dae Hyuk, et al.
Publicado: (2023)

Complete biochemical response after stereotactic ablative radiotherapy of an isolated prostate cancer pelvic soft tissue recurrence detected by 18F-DCFPyL PET/CT
por: Phillips, Ryan M., et al.
Publicado: (2017)

Predicting biochemical recurrence and prostate cancer‐specific mortality after radical prostatectomy: comparison of six prediction models in a cohort of patients with screening‐ and clinically detected prostate cancer
por: Remmers, Sebastiaan, et al.
Publicado: (2019)

Local recurrence of prostatic ductal adenocarcinoma despite clear surgical margins
por: Merrett, Christopher, et al.
Publicado: (2018)

Testicular recurrence of oligometastatic prostatic adenocarcinoma after 22 years of androgen deprivation therapy
por: Fortier, Alexa, et al.
Publicado: (2022)

Management of Isolated Local Failures Following Stereotactic Body Radiation Therapy for Low to Intermediate Risk Prostate Cancer
por: Aghdam, Nima, et al.
Publicado: (2020)

Favorable Biochemical Freedom From Recurrence With Stereotactic Body Radiation Therapy for Intermediate and High-Risk Prostate Cancer: A Single Institutional Experience With Long-Term Follow-Up
por: Ricco, Anthony, et al.
Publicado: (2020)

Gene signatures predict biochemical recurrence‐free survival in primary prostate cancer patients after radical therapy
por: Su, Qiang, et al.
Publicado: (2021)

A Glycolysis-Related Five-Gene Signature Predicts Biochemical Recurrence-Free Survival in Patients With Prostate Adenocarcinoma
por: Xu, Zijun, et al.
Publicado: (2021)

Fluciclovine positron emission tomography in the setting of biochemical recurrence following local therapy of prostate cancer
por: Glaser, Zachary A., et al.
Publicado: (2018)

The Use of High-Intensity Focused Ultrasound (HIFU) Plus 150mg Bicalutamide as First Line Salvage Therapy for Local Recurrent Prostate Cancer
por: Cao, Jian-zhou, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jm13cosn0aar1hls3ucgnm14qh